Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs

Archives of Gerontology and Geriatrics

Volumn 24, Issue 2, 1997, Pages 223-231

  Garfinkel, D ^a,b   Laudon, M ^c   Zisapel, N ^d  

^a WOLFSON MEDICAL CENTER   (Israel)

^b Meonot Maccabi   (Israel)

^c NEURIM PHARMACEUTICALS LTD   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Benzodiazepines; Elderly; Insomnia; Melatonin

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HORMONE; MELATONIN; UNCLASSIFIED DRUG;

AGED; AROUSAL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INSOMNIA; LATENT PERIOD; MALE; PINEAL BODY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP TIME; SLEEP WAKING CYCLE;

EID: 0031014871     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(96)00754-6     Document Type: Article

References (18)

1. Acuna-Castroviejo, D. and Cardinali, D.P. (1986): Diurnal variation of benzodiazepine binding in rat cerebral cortex: disruption by pinealectomy. J. Pineal Res., 3, 101-102.
2. Arendt, J. (1988): Melatonin. Clin. Endocrinol., 29, 205-229.
3. Arendt, J., Bojkowski, C., Franey, C., Wright J. and Marks, V. (1985): Immunoassay of 6-hydroxymelatonin sulphate in human plasma and urine. Abolition of the urinary 24-h rhythm with atenolol. J. Clin. Endocrinol. Metab., 60, 1166-1173.
4. Atsmon, J., Okanin, S., Laudon, M., Laschiner, S., Gavish, M., Dagan, Y. and Zisapel, N. (1996): Reciprocal effects of chronic diazepam and melatonin on brain melatonin and benzodiazepine binding sites. J. Pineal Res., 20, 65-71.
5. Brooks, J.O., Friedman, L., Bliwise, D.L. and Yesavage, J.A. (1993): Use of wrist actigraph to study insomnia in older adults. Sleep, 16, 151-155.
6. Cardinali, D.P., Lowenstein, P.R. and Rosenstein, R.E. (1986): Functional links between benzodiazepine and GABA receptors and pineal activity. Adv. Biochem. Psychopharmacol., 42, 155-164.
7. Cole, R.J., Kripke, D.F., Gruen, W., Mullaney, D.J. and Gillin, J.C. (1992): Automatic sleep/wake identification from wrist activity. Sleep, 15, 461-469.
8. Dawson, D. and Encel, N. (1993): Melatonin and sleep in humans. J. Pineal Res., 15, 1-12.
9. Garfinkel, D., Laudon, M., Nof, D. and Zisapel, N. (1995): Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet, 346, 541-544.
10. 3H-flunitrazepam binding. Neuroendocrinology, 4, 987-990.
11. Haimov, I., Laudon, M., Zisapel, N., Souroujon, M., Nof, D., Shlitner, A., Herer, P., Tzischinsky, O. and Lavie, P. (1994): Sleep disorders and melatonin rhythms in elderly people. Br. Med. J., 309, 167.
12. Haimov, I., Lavie, P., Laudon, M., Herer, P., Vigdor, C. and Zisapel, N. (1995): Melatonin replacement therapy of elderly insomniacs. Sleep, 18, 598-603.
13. Kopin, I.J., Pare, C.M.B., Axelrod, J. and Weissbach, H. (1961): The fate of melatonin in animals. J. Biol. Chem., 236, 3072-3078.
14. Kveder, S. and McIssac, W.M. (1961): The metabolism of melatonin (N-acetyl-5-methoxytryptamine) and 5-methoxytryptamine. J. Biol. Chem., 236, 3214-3220.
15. Lushington, K., Lack, L. and Dawson, D. (1995): Melatonin production in good and poor elderly sleepers. Sleep Res., 24A, 168.
16. McIntyre, I.M., Burrows, G.D. and Norman, T.R. (1988) Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans. Biol. Psychiatry, 24, 105-108.
17. Sharma, M., Palacios-Bois, J., Schwartz, G., Iskandar, H., Thakur, M., Quirion, R. and Nair, N.P.V. (1989): Circadian rhythms of melatonin and cortisol in aging. Biol. Psychiatry, 25, 305-319.
18. Waldhauser, F., Waldhauser, M., Liberman, H.R., Deng, M.H., Lynch, H.J. and Wurtman, R.J. (1984): Bioavailability of oral melatonin in humans. Neuroendocrinology, 39, 307-313.